ClinicalTrials.gg
CompletedNCT07892430Updated Oct 23, 2026

Psychological, Hormonal, and Physical Performance Profiles in Adolescent Male Football Players: An Exploratory Cross-Sectional Study

An observational study in Adolescence, Body Composition and Physical Performance, sponsored by Firat University. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 11 Years to 15 Years. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Firat University · Observational

Updated Oct 23, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
21
Ages
11 Years to 15 Years
Sex
Male
01

Study summary

This study aimed to examine the relationships among psychological characteristics, hormonal markers, body composition, and physical performance in adolescent male football players. Twenty-one male football players participated in this cross-sectional correlational study. Assessments included anthropometric measurements, jumping, sprinting, agility, kick speed, psychological well-being in sport, and mental toughness. Blood samples were collected to measure testosterone, FT3, and FT4 levels. Data were examined using partial correlation network analysis, centrality analysis, hierarchical clustering, and principal component analysis.

Read the detailed description

This study was designed to examine conditional associations and similarity-based patterns among psychological, hormonal, and physical characteristics in adolescent male football players. It employed a cross-sectional correlational design and did not involve any training or therapeutic intervention.

Assessments were conducted during measurement sessions held on separate days. These sessions included evaluations of body composition, motor performance, and psychological characteristics. Venous blood samples were collected for hormonal analyses.

The analytical approach included network analysis to examine conditional associations among variables, centrality measures to assess their positions within the network, and hierarchical clustering to identify groups of variables with similar characteristics. Principal component analysis was used to summarize the multivariate data structure. Given the cross-sectional design, the analyses were intended to explore associations and patterns within the study sample rather than establish causal relationships.

02

Conditions studied

  • Adolescence
  • Body Composition
  • Physical Performance
  • Mental Toughness

Keywords

  • anaerobic performance
  • football experience
  • hormon
  • well-being
03

In context

Lead sponsor

Firat University is the lead sponsor of 117 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 15 Years
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consisted of adolescent male football players aged 12-14 years who actively played for a single U-14 football team in Bingöl, Türkiye, and participated in regular football training. Twenty-one players voluntarily participated in the study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participation in regular football training.
  • No health issues or injuries that would prevent completion of motor performance tests and psychological assessments.
  • Agreement to attend all scheduled measurement sessions.

Exclusion criteria

Exclusion Criteria:

  • - Non-adherence to the research protocol.
  • Use of medications that could affect measurements.
  • Presence of a medical condition that could influence hormonal and physiological status.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
21 participants (actual)
Patient registry
No

Groups and cohorts

  • Adolescent Male Football Players

    Adolescent male football players underwent anthropometric and body composition assessments, physical performance tests, and psychological questionnaires during measurement sessions held on separate days. Venous blood samples were collected to measure testosterone, free triiodothyronine (FT3), and free thyroxine (FT4) levels. No training or therapeutic intervention was administered.

06

What researchers measure

Primary outcomes

  1. Hormonal Markers, Psychological Scores, Physical Performance, and Body Composition

    Serum total testosterone, free triiodothyronine (FT3), and free thyroxine (FT4) were measured by immunoassay in a 5 mL venous blood sample collected after at least 12 hours of fasting. Psychological well-being was assessed using a 23-item scale (23-115 points), and mental toughness using an eight-item index (mean score: 1-7); higher scores indicate better well-being or toughness. Countermovement jump height was measured using a jump mat, standing long jump distance using a tape, 10 and 20 m sprint and T-test times using electronic timing, and kick speed using radar. The best of two trials was retained; higher jump and kick speed values and shorter times indicate better performance. Body weight, BMI, body fat percentage, and skeletal muscle percentage were assessed using bioelectrical impedance, and height using a stadiometer.

    Time frame: Assessed once per participant across four assessment sessions spaced 48 hours apart, over approximately 6 days from the first to the final session.

  2. - Total testosterone, FT3, and FT4 levels - Psychological well-being in sport and mental toughness scores - Jump, sprint, change-of-direction, and kick speed performance - Body composition measures used in the analysis

    Serum total testosterone, free triiodothyronine (FT3), and free thyroxine (FT4) were measured by immunoassay in a 5 mL venous blood sample collected after at least 12 hours of fasting. Psychological well-being was assessed using a 23-item scale (23-115 points), and mental toughness using an eight-item index (mean score: 1-7); higher scores indicate better well-being or toughness. Countermovement jump height was measured using a jump mat, standing long jump distance using a tape, 10 and 20 m sprint and T-test times using electronic timing, and kick speed using radar. The best of two trials was retained; higher jump and kick speed values and shorter times indicate better performance. Body weight, BMI, body fat percentage, and skeletal muscle percentage were assessed using bioelectrical impedance, and height using a stadiometer.

    Time frame: Assessed once per participant across four assessment sessions spaced 48 hours apart, over approximately 6 days from the first to the final session.

07

Study locations

1 site
  • Firat University, Faculty of Sport Science
    Elâzığ, Merkez 23119, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07892430
Lead sponsor
Firat University
Responsible party
Taner Akbulut (Prof., Firat University) — Principal investigator
First posted
Oct 23, 2026
Start date
Mar 5, 2026
Primary completion
Jun 9, 2026
Completion
Jul 9, 2026
Last update
Oct 23, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion